Project Nightingale: Google deals with Ascension, obtains medical records
Google accumulates data from search, email, and maps and clearly knows how people live. One treasure trove of data has eluded Google, healthcare information. As...
BRCA and CNS Metastasis
Since sequenced in 1994-1995, BRCA1 and BRCA2 are known to be phenotypically different. Whereas most BRCA1 tumors are high-grade and ER-negative, most BRCA2 tum...
BREAST CANCER INCIDENCE RISING AS PLUNGE IN DEATH RATE BEGINS TO SLOW
There are currently 3.8 million women with a history of breast cancer living in the United States. Since 1989 the death rate has plunged 40%. According to the A...
DCIS WITH MICROINVASION ON CORE BIOPSY. SENTINEL NODE BIOPSY?
Approximately 10% of patients having DCIS on core biopsy will be found to have microinvasion on surgical excision (DCISM). When considering sentinel node biopsy...
IMPACT OF CURRENT TECHNOLOGY ON PATIENT EVALUATION
Marking the publication of his latest tome, Talking to Strangers, Malcolm Gladwell sat down for an interview for Web MD magazine with Lauren Paige Kennedy. Glad...
BREAST CANCER SUBTYPE EXCESS FAMILIAL CLUSTERING
Pedigree with familial clustering of mucinous carcinoma
REDEFINING THE SENSITIVITY OF SCREENING MAMMOGRAPHY: A REVIEW
From its inception, screening mammography has enjoyed a perceived level of sensitivity that is inconsistent with available evidence. The original data that impa...
FEATURED, Research, Metastatic breast cancer
STUDIES SUGGEST THE PRESENCE OF ESR1 MUTATION IMPACTS CHOICE OF THERAPY IN ER+ METASTATIC BREAST CANCER
Presence of mutant ESR1 may stimulate endocrine resistance Hormonal therapy benefits approximately 30% of patients with metastatic breast cancer. By adding CDK ...
Beyond BRCA Testing in Hispanic Population Founder Mutations in PALB2 and CHEK2 Predominate
Hispanic Americans are a rapidly growing segment of the United States population. Approximately 1 in 12 will develop breast cancer. The prognosis for these wome...
Are Androgen Receptors Receiving Proper Respect?
Lonergan et al, Journal of Carcinogenesis 2011
Subscribe to Updates
TOPICS
- FEATURED (92)
- News (73)
- Industry (42)
- Opinion (33)
- Risk Assessment (33)
- Research (32)
- Genetics (20)
- Genomics (15)
- Cases (14)
- Surgery (12)
- Video (12)
- Coding (10)
- Resources (10)
- Genetic Testing (9)
- Tools (9)
- Imaging (7)
- Margins (6)
- Radiation (6)
- Biopsy (5)
- Neoadjuvant Treatment (5)
- Biology (4)
- Breast Cancer (3)
- Oncoplastic (3)
- Tumor Localization (3)
- BRCA (2)
- Chemotherapy (2)
- Events (2)
- Germline (2)
- Lymphedema (2)
- Metastatic breast cancer (2)
- Regional Management (2)
- Techniques (2)
- Uncategorized (2)
- Biologic Therapy (1)
- CRISPR (1)
- Diagnosis (1)
- Fertility (1)
- Genetic Engineering (1)
- Health care economics (1)
- Histology (1)
- Neoadjuvant Therapy (1)
- PARP Inhibitors (1)
- Pregnancy (1)
- Subtypes (1)
- links (1)